Founded Year

2006

Stage

Series D - II | Alive

Total Raised

$134.32M

Last Raised

$15.35M | 7 days ago

Mosaic Score

+10 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Xeltis

Xeltis is a clinical-stage company developing medical devices that enable cardiovascular restoration. The Xeltis medical device platform comprises of bioabsorbable heart valves and blood vessels that are designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. Xeltis was founded in 2006 and is based in Zurich, Switzerland.

Xeltis Headquarter Location

Seefeldstrasse 69

Zurich, 8008,

Switzerland

+31 40 751 7614

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Xeltis's Products & Differentiation

See Xeltis's products and how their products differentiate from alternatives and competitors

  • Pulmonary valve

    Biodegredable pulmonary valve that incites the body to take over functionality and regrow own valve

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing Xeltis

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Xeltis is included in 4 Expert Collections, including Regenerative Medicine.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

M

Medical Devices

8,449 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

H

Health IT

7,900 items

Xeltis Patents

Xeltis has filed 21 patents.

The 3 most popular patent topics include:

  • Cardiac surgery
  • Implants (medicine)
  • Angiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/19/2018

3/23/2021

Paragliders, Biomaterials, Polymers, Thermoplastics, Tissue engineering

Grant

Application Date

12/19/2018

Grant Date

3/23/2021

Title

Related Topics

Paragliders, Biomaterials, Polymers, Thermoplastics, Tissue engineering

Status

Grant

Xeltis Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Xeltis Rank

  • When was Xeltis founded?

    Xeltis was founded in 2006.

  • Where is Xeltis's headquarters?

    Xeltis's headquarters is located at Seefeldstrasse 69, Zurich.

  • What is Xeltis's latest funding round?

    Xeltis's latest funding round is Series D - II.

  • How much did Xeltis raise?

    Xeltis raised a total of $134.32M.

  • Who are the investors of Xeltis?

    Investors of Xeltis include China Grand Pharmaceutical & Healthcare, European Investment Bank, Kurma Partners, VI Partners, Life Sciences Partners and 3 more.

  • Who are Xeltis's competitors?

    Competitors of Xeltis include Humacyte and 3 more.

  • What products does Xeltis offer?

    Xeltis's products include Pulmonary valve and 1 more.

You May Also Like

CareTaker Medical Logo
CareTaker Medical

CareTaker Medical is a wireless patient monitor. It uses only a finger cuff to measure continuous beat-by-beat blood pressure, heart rate, and other physiological parameters enabling remote patient monitoring via its secure Android app, cloud portals, or interfaced with other patient monitoring systems.

C
Cala Health

Cala Health develops wearable neuromodulation therapies to deliver individualized peripheral nerve stimulation. It was founded in 2014 and is based in San Mateo, California.

C
Cardiac Insight

Cardiac Insight is focused on developing advanced body-worn sensing and computing technologies for diagnostic testing in cardiology, respiratory, and other complex disease states. The company seeks to do more than incrementally improve diagnostics and treatment, but rather to invent complete solutions to unmet clinical needs.On March 16th, 2022, Cardiac Insight was acquired by DreamTech. The terms of the transaction were not disclosed.

Nuvaira Logo
Nuvaira

Nuvaira is a privately held company headquartered in Minneapolis, MN. The company’s proprietary Nuvaira Lung Denervation System addresses airway hyper-responsiveness, a pathophysiologic underpinning of both COPD and asthma, in a procedure called Targeted Lung Denervation (TLD). The Nuvaira Lung Denervation System is under clinical investigation and is not commercially available in the USA, and is CE Mark approved.

TytoCare Logo
TytoCare

TytoCare connects people to clinicians to provide virtual home examinations and diagnosis solutions. TytoCare's solutions are designed to enable a comprehensive medical exam with clinicians, from any location.

Rune Labs Logo
Rune Labs

Rune Labs works with existing and emerging neuromodulation systems to manage complex therapies and get value out of available healthcare data.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.